Shares in Perrigo slump to 9-year low
Company confirmed it faces Revenue demand for €1.64bn in back taxes
Perrigo shares slide as drugmaker slashes full-year forecast again
Company sales have halved since the company rejected Mylan takeover offer late last year
Valeant is selling assets to help pay down long-term debt
Announcement by Canadian pharmaceutical company drives its shares up by 13%
Shake-up at Valeant signals stunning fall from grace for J Michael Pearson
Pharmaceutical giant faces a growing list of questions from investors and regulators
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices